TokenPost·
Humacyte Plans November Dialysis Application, Projects Fourth-Quarter Symvess Sales
The filing would be a supplemental biologics license application, or sBLA.
More news
- TokenPostKomodo (KMD) Jumps 17.84% in an Hour, Reaching $0.005041
- TokenPostInitia Blames Leaked GCP Key for $3.27 Million Crypto Theft
- TokenPostSolanaMobile Names CLOCK IN Hackathon Winners as Breakpoint 2026 Nears
- TokenPostAcross Warns Users to Avoid Its App During Domain Investigation
- TokenPostCrescent Capital BDC Authorizes Up to $50 Million in Share Repurchases
- TokenPostMicron Shares Rise Just Over 13% as Monthlong Slide Reverses